Herpes Simplex Virus (HSV)


Active/Enrolling:

None at this time; please check back soon.

Closed to Enrollment:

None at this time; please check back soon.

Pending:

PRIOH-1

  • Principal Investigator: Gary Wang, MD, PhD
  • https://www.aicuris.com/75n6/Pritelivir-AIC316-.htm
  • In this study, immunocompromised patients with the herpes simplex virus (HSV) have ulcers that are usually very deep, extensive, and associated with severe pain that poses a risk for serious complications. The standard treatment of acyclovir or valacyclovir is no longer working against acyclovir-resistant (ACV-R) HSV infection that can occur in any immunocompromised patient. This study seeks to evaluate the efficacy and safety of pritelivir, an oral inhibitor of HSV replication, for treatment of ACV-R HSV infections in immunocompromised adults with the aim to offer alternative treatment.
  • Contact: Steven Fowler, 352-294-5277, stevenfowler@ufl.edu

Completed:

None at this time; please check back soon.